About Me

I am a biotechnology entrepreneur and consultant focused on building science-driven companies that bridge critical gaps in healthcare and research. My work centers on advancing in vitro disease modeling platforms to improve drug development and on transforming women’s health through diagnostics, data insights, and targeted interventions.

​

Over the past year, I have advised biotech companies on strategic growth, business development, and fundraising, helping founders and teams scale innovative platforms from early-stage concepts to operational businesses.

​

Previously, I co-founded and served as CEO of Known Medicine, where we developed one of the most high-throughput patient-derived tumor organoid platforms for drug discovery and development. Following Known Medicine’s acquisition by Pathos in 2023, I served as Vice President of Partnerships at Pathos, leading strategic collaborations and growth initiatives.

​

I hold a Ph.D. in Biomedical Engineering from the Virginia Tech – Wake Forest University School of Biomedical Engineering and Sciences, with more than a decade of research experience spanning tissue engineering, biomaterials, and oncology. My work has led to 17 peer-reviewed publications and presentations at major national and international conferences.

​

At the core of my work is a passion for translating complex science into tangible solutions that drive real-world impact - through building, advising, and scaling companies that improve patient outcomes and advance the future of medicine.